19 Jan 2018

Nilotinib, sold under the brand name Tasigna, is used in the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+CML). The prescription drug is manufactured by Novartis and works by inhibiting a protein that helps cancer cells grow and proliferate without harming normal healthy cells in the body. However, Tasigna has been associated with a serious condition called ...